
Merck to acquire Prometheus Biosciences for US$10.8bn
MULTINATIONAL pharmaceutical company Merck will buy Prometheus Biosciences for about US$10.8bn, a...
MULTINATIONAL pharmaceutical company Merck will buy Prometheus Biosciences for about US$10.8bn, a...
BIONTECH has signed a collaboration agreement with Matinas BioPharma to advance formulations for ...
A STOCKPILE of Ebola vaccine has been established by humanitarian organisations to help better pr...
FOLLOWING three highly-encouraging Covid-19 vaccine trials, the light at the end of the tunnel su...
A WORKFLOW has been developed that allows for high precision manufacturing of active pharmaceutic...
JAPAN’S Takeda Pharmaceutical has revealed it is considering a bid for Ireland’s Shire as it seek...
A STUDY has shown that near-infrared chemical imaging (NIR CI) can be used for monitoring the mix...
A NEW method has been developed to help drug developers weed out compounds that could potentially...
ROCHE has agreed a deal to buy oncology drug company Ignyta for US$27/share, a total of US$1.7bn.
Coalition seeks sustainable vaccine development
Distributor Flynn Pharma also fined
CMA rules GSK kept generic alternatives from market
Catch up on the latest news, views and jobs from The Chemical Engineer. Below are the four latest issues. View a wider selection of the archive from within the Magazine section of this site.